Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djaf201 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Emma Hazelwood und 20 weiteren Autor:innen. Beteiligte Einrichtung: MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: Obesity, Adiposity, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Integrative Cancer Epidemiology Programme, French National Cancer Institute.
Abstract (Originalsprache)
Introduction
There is convincing evidence that overall adiposity increases the risks of several cancers. Whether the distribution of adiposity plays a similar role is unclear.
Methods
We used 2-sample Mendelian randomization (MR) to examine causal relationships of 5 adiposity distribution traits (abdominal subcutaneous adipose tissue (ASAT); visceral adipose tissue (VAT); gluteofemoral adipose tissue (GFAT); liver fat; and pancreas fat) with the risks of 12 obesity-related cancers (endometrial, ovarian, breast, colorectal, pancreas, multiple myeloma, liver, kidney (renal cell), thyroid, gallbladder, esophageal adenocarcinoma, and meningioma).
Results
Sample size across all genome-wide association studies (GWAS) ranged from 8407 to 728 896 (median: 57 249). We found evidence that higher genetically predicted ASAT increased the risks of endometrial cancer, liver cancer, and esophageal adenocarcinoma (odds ratios (OR) and 95% confidence intervals (CI) per standard deviation (SD) higher ASAT = 1.79 (1.18 to 2.71), 3.83 (1.39 to 10.53), and 2.34 (1.15 to 4.78), respectively). Conversely, we found evidence that higher genetically predicted GFAT decreased the risks of breast cancer and meningioma (ORs and 95% CIs per SD higher genetically predicted GFAT = 0.77 (0.62 to 0.97) and 0.53 (0.32 to 0.90), respectively). We also found evidence for an effect of higher genetically predicted VAT and liver fat on increased liver cancer risk (ORs and 95% CIs per SD higher genetically predicted adiposity trait = 4.29 (1.41 to 13.07) and 4.09 (2.29 to 7.28), respectively).
Discussion
Our analyses provide novel insights into the relationship between adiposity distribution and cancer risk. These insights highlight the potential importance of adipose tissue distribution alongside maintaining a healthy weight for cancer prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
- Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC- WHO), Lyon, France.
- Clinical and Biomedical Sciences, University of Exeter, Exeter, United Kingdom.
- Department of Upper GI and Bariatric/Metabolic Surgery, North Bristol NHS Trust, Southmead Hospital, Bristol, United Kingdom.
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID-Profile: Emma Hazelwood, Lucy J Goudswaard, Matthew A Lee, Dimitri J Pournaras, Hermann Brenner, Daniel D Buchanan, Stephen B Gruber, Andrea Gsur, Li Li, Ludmila Vodickova, N Jewel Samadder, Marc J Gunter, James Yarmolinsky, Tom G Richardson, Heinz Freisling, Emma E Vincent
Förderung
- Medical Research Council
- Integrative Cancer Epidemiology Programme
- French National Cancer Institute
- Cancer Research UK 25
- Medical Research Council Integrative Epidemiology Unit
- Czech Health Research Council
- Cancer Research UK
- NCI NIH HHS
Zitieren
APA
Hazelwood, E., Goudswaard, L. J., Lee, M. A., Vabistsevits, M., Pournaras, D. J., Brenner, H., Buchanan, D. D., Gruber, S. B., Gsur, A., Li, L., Vodickova, L., Grant, R. C., Samadder, N. J., Timpson, N. J., Gunter, M. J., Schuster-Böckler, B., Yarmolinsky, J., Richardson, T. G., Freisling, H., …, & Vincent, E. E. (2025). Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf201
Vancouver
Hazelwood E, Goudswaard LJ, Lee MA, Vabistsevits M, Pournaras DJ, Brenner H, et al. Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf201
BibTeX
@article{Hazelwood2025,
author = {Hazelwood, Emma and Goudswaard, Lucy J and Lee, Matthew A and Vabistsevits, Marina and Pournaras, Dimitri J and Brenner, Hermann and Buchanan, Daniel D and Gruber, Stephen B and Gsur, Andrea and Li, Li and Vodickova, Ludmila and Grant, Robert C and Samadder, N Jewel and Timpson, Nicholas J and Gunter, Marc J and Schuster-Böckler, Benjamin and Yarmolinsky, James and Richardson, Tom G and Freisling, Heinz and Murphy, Neil and Vincent, Emma E},
title = {Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djaf201}
}
EUVIMED